Menopause is often discussed as though it were one prolonged stage, but clinically the terminology is more precise. Perimenopause is the transition around the final menstrual period; menopause is a specific retrospective time point, and postmenopause describes the years that follow. Understanding this timeline matters because menstrual patterns, symptoms, reproductive considerations and long-term health priorities do not remain the same throughout the transition.

The World Health Organization describes menopause as part of a continuum of reproductive ageing rather than a disease. Natural menopause most commonly occurs between 45 and 55 years and is confirmed after 12 consecutive months without menstruation when no other physiological, pathological or treatment-related explanation is present (World Health Organization [WHO], 2024).

1. The Clinical Map: Where Is the Patient on the Timeline?

The Stages of Reproductive Ageing Workshop +10, or STRAW+10, provides the standard framework for describing reproductive ageing. Changes in menstrual-cycle pattern are particularly useful because reproductive hormones can fluctuate considerably during the transition (Harlow et al., 2012).

A common examination error is therefore to describe menopause as lasting several years. It does not. The transition may last several years, but menopause itself refers to the final menstrual period once it has been retrospectively confirmed (Harlow et al., 2012; WHO, 2024).

Perimenopause: The Variable Transition

Perimenopause usually begins when ovarian follicular function becomes increasingly variable. Ovulation becomes less predictable, oestrogen concentrations fluctuate and follicle-stimulating hormone levels tend to rise. Because hormone production is fluctuating rather than simply declining in a straight line, symptoms can also vary considerably from month to month (Hoffman et al., 2020).

Changes in menstrual pattern are often among the first recognisable features. Cycles may become shorter or longer, periods may be skipped, and bleeding volume may change. Vasomotor symptoms such as hot flushes and night sweats may appear alongside sleep disturbance, fatigue, difficulty concentrating, mood changes, headaches, joint or muscle symptoms and altered sexual or genitourinary health. Individual experience varies substantially; some patients have minimal symptoms while others experience considerable interference with work, exercise and daily activity (WHO, 2024).

Importantly, pregnancy remains possible during perimenopause because intermittent ovulation can still occur. Amenorrhoea for a few months should therefore not automatically be interpreted as established menopause (WHO, 2024).

For otherwise healthy people aged 45 years or older with typical symptoms and menstrual changes, menopause is generally identified clinically rather than through routine hormone testing. Hormonal investigations become more relevant when the presentation is atypical, the patient is younger, menstruation cannot be interpreted reliably, or another endocrine or reproductive disorder is suspected (National Institute for Health and Care Excellence [NICE], 2024).

Menopause: A Time Point, Not a Symptom Syndrome

Natural menopause results from loss of ovarian follicular function and declining ovarian oestrogen production. Clinically, it is diagnosed retrospectively after 12 consecutive months without menstruation, provided there is no alternative cause of amenorrhoea (WHO, 2024).

This means that a patient who has not menstruated for six months may be in the late menopausal transition, but natural menopause cannot yet be confirmed simply on the basis of that six-month interval.

Menopause may also be induced. Bilateral removal of the ovaries produces surgical menopause, while chemotherapy, radiotherapy and some medical treatments can impair ovarian function. The resulting hormonal change may be more abrupt than natural menopause and requires appropriate medical management.

Age also matters. Menopause substantially earlier than the usual population range should not simply be labelled a normal variation. Menstrual cessation before 40 years raises concern for premature ovarian insufficiency, while menopause occurring at an unusually young age also deserves medical assessment because prolonged oestrogen deficiency has implications for bone and cardiovascular health (NICE, 2024).

Postmenopause: The Clinical Focus Begins to Shift

Once menopause has occurred, the patient enters the postmenopausal years. Hot flushes, sleep disturbance and other transition-related symptoms do not necessarily disappear immediately, but the clinical emphasis gradually expands from symptom management toward healthy ageing.

Declining oestrogen exposure contributes to accelerated bone loss around menopause, making osteoporosis and fracture prevention increasingly important. Changes in body composition, cardiovascular risk and skeletal-muscle function may also become clinically relevant. Genitourinary symptoms can persist or become more prominent because reduced oestrogen affects vulvovaginal and lower urinary tract tissues (WHO, 2024).

The term 'genitourinary syndrome of menopause' (GSM) includes symptoms such as vaginal dryness, irritation, discomfort during intercourse and urinary symptoms. Unlike many vasomotor symptoms, GSM frequently persists without appropriate treatment.

Postmenopausal bleeding requires particular attention. Once menopause has been established, new vaginal bleeding should not be assumed to be a normal hormonal fluctuation and requires medical or gynaecological evaluation.

Hormone therapy remains the most effective medical treatment for troublesome vasomotor symptoms and is also effective for GSM while helping prevent bone loss. Treatment decisions are individualised according to symptoms, age, time since menopause, medical history and patient preferences rather than being universally prescribed (The North American Menopause Society [NAMS], 2022).

What Should the Physiotherapist Assess?

Menopause itself is not a physiotherapy diagnosis, but its consequences can influence many presentations seen in rehabilitation. A clinician should therefore avoid attributing every new symptom to hormonal change while still recognising menopause as an important part of the health history.

Assessment may include menstrual and menopause history, current symptoms, medication and hormone therapy history, cardiovascular risk factors, blood pressure, physical activity level, musculoskeletal pain, previous fractures, strength, balance and functional capacity. Sleep disturbance and fatigue may substantially affect exercise tolerance and adherence.

Pelvic-health screening is particularly relevant when the patient reports urinary leakage, urgency, vaginal heaviness, constipation, sexual discomfort or pelvic pain. Evidence supports pelvic-floor muscle training for urinary incontinence in postmenopausal women, although treatment should follow individual assessment rather than assuming that every patient simply requires strengthening (Marcellou et al., 2025).

Clinicians should also consider alternative explanations for symptoms. Fatigue, palpitations, altered bleeding, weight change or reduced exercise tolerance may reflect thyroid disease, anaemia, cardiovascular disease, medication effects, sleep disorders or other medical conditions rather than menopause alone.

Exercise and Rehabilitation Across the Menopause Transition

Exercise should be viewed primarily as a strategy for maintaining physical capacity and reducing long-term health risk, rather than as a replacement for medical treatment of menopausal symptoms.

A balanced programme should progressively incorporate aerobic activity, resistance exercise, weight-bearing loading, balance work and mobility according to the patient’s health status and previous activity. General exercise guidance continues to support regular aerobic activity together with muscle-strengthening exercise on at least two days per week, adapted for comorbidities and functional capacity (Ozemek et al., 2025).

Resistance and appropriately prescribed weight-bearing exercise are especially important as bone and muscle health become greater priorities. Patients with osteoporosis, fragility fractures, significant cardiovascular disease or long periods of inactivity may require more careful screening and graded progression.

Exercise may additionally support mood, sleep, body composition, confidence and general quality of life. However, clinicians should be cautious about promising that a particular exercise programme will eliminate hot flushes. A 2024 overview of systematic reviews found some benefits from physical activity interventions, particularly yoga and some aerobic approaches, but evidence for specific improvement in vasomotor and psychological symptoms remained inconsistent (Money et al., 2024).

This distinction is clinically useful: exercise remains strongly justified even when it does not directly remove every menopausal symptom.

Viva-Ready Clinical Summary

Think of reproductive ageing as a timeline rather than three interchangeable labels.

Perimenopause is the variable transition in which menstrual cycles and ovarian hormone production become increasingly irregular. Symptoms such as hot flushes, disturbed sleep and mood changes often begin during this phase, but ovulation and pregnancy remain possible.

Menopause is a single retrospective diagnosis. Natural menopause is confirmed after 12 consecutive months of amenorrhoea without another identifiable cause.

'Postmenopause' describes the years following menopause. Symptoms may continue, but clinical priorities increasingly include bone health, cardiovascular risk, muscle function, pelvic-floor and genitourinary health and long-term healthy ageing.

For physiotherapists, the key role is not to “correct hormones". It is to identify how the transition affects function, prescribe appropriate exercise and pelvic-health rehabilitation, recognise risk factors and refer when symptoms require medical investigation.

One-line recall:
Perimenopause is the transition; menopause is the final menstrual-period milestone; postmenopause is the life stage that follows.

References

Harlow, S. D., Gass, M., Hall, J. E., Lobo, R., Maki, P., Rebar, R. W., Sherman, S., Sluss, P. M., & de Villiers, T. J. (2012). Executive summary of the Stages of Reproductive Ageing Workshop +10: Addressing the unfinished agenda of staging reproductive ageing. Menopause, 19(4), 387–395.

Hoffman, B. L., Schorge, J. O., Bradshaw, K. D., Halvorson, L. M., Schaffer, J. I., & Corton, M. M. (2020). Williams gynecology (4th ed.). McGraw Hill.

Marcellou, E. G., Stasi, S., Giannopapas, V., Bø, K., Bakalidou, D., Konstadoulakis, M., & Papathanasiou, G. (2025). Effect of pelvic floor muscle training on urinary incontinence symptoms in postmenopausal women: A systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology, 304, 134–140. https://doi.org/10.1016/j.ejogrb.2024.11.040

Money, A., MacKenzie, A., Norman, G., Eost-Telling, C., Harris, D., McDermott, J., & Todd, C. (2024). The impact of physical activity and exercise interventions on symptoms for women experiencing menopause: Overview of reviews. BMC Women's Health, 24, 399. https://doi.org/10.1186/s12905-024-03243-4

National Institute for Health and Care Excellence. (2024). Menopause: Identification and management (NICE Guideline NG23).

Ozemek, C., Bonikowske, A., Christle, J., & Gallo, P. (2025). ACSM's guidelines for exercise testing and prescription (12th ed.). Wolters Kluwer.

The North American Menopause Society. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767–794. https://doi.org/10.1097/GME.0000000000002028

World Health Organization. (2024). Menopause.